Amneal Pharmaceuticals AMRX

$ 5.91 2.6%

Quarterly report 2024-Q3
added 11-12-2024

Amneal Pharmaceuticals Balance Sheet 2011-2024 | AMRX

Annual Balance Sheet Amneal Pharmaceuticals

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	2.33 B	2.6 B	2.46 B	2.47 B	2.48 B	2.44 B	1.37 B	-	-	-	-	-	-
Long Term Debt	2.39 B	2.59 B	2.68 B	2.77 B	2.61 B	2.63 B	1.36 B	-	-	-	-	-	-
Long Term Debt Current	34.1 M	30 M	30.6 M	44.2 M	21.5 M	21.4 M	-	-	-	-	-	-	-
Total Non Current Liabilities	2.56 B	2.84 B	2.88 B	2.98 B	2.77 B	2.9 B	1.42 B	-	-	-	-	-	-
Total Current Liabilities	847 M	753 M	677 M	677 M	550 M	554 M	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	3.32 B	3.46 B	1.72 B	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-490 M	-406 M	-276 M	-287 M	-378 M	-20.9 M	-	-	-	-	-	-	-
Total Assets	3.47 B	3.8 B	3.94 B	4.01 B	3.67 B	4.35 B	1.34 B	-	-	-	-	-	-
Cash and Cash Equivalents	91.5 M	26 M	248 M	341 M	151 M	213 M	74.2 M	37.5 M	-	-	-	-	-
Book Value	3.47 B	3.8 B	3.94 B	4.01 B	347 M	896 M	-376 M	-	-	-	-	-	-
Total Shareholders Equity	19.8 M	298 M	367 M	345 M	232 M	505 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Amneal Pharmaceuticals

	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	2.17 B	2.18 B	2.38 B	-	2.55 B	2.56 B	2.59 B	2.61 B	2.62 B	2.67 B	2.68 B	2.69 B	2.72 B	2.73 B	2.74 B	2.74 B	2.74 B	2.74 B	2.61 B	2.61 B	2.61 B	2.61 B	2.63 B	2.63 B	2.63 B	2.63 B	1.36 B	-	1.36 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	2.4 B	2.4 B	2.64 B	-	2.74 B	2.76 B	2.84 B	2.84 B	2.86 B	2.86 B	2.88 B	2.91 B	2.95 B	2.94 B	2.97 B	2.97 B	2.97 B	2.97 B	2.77 B	2.77 B	2.77 B	2.77 B	2.9 B	2.9 B	2.9 B	2.9 B	1.42 B	1.42 B	1.42 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-576 M	-576 M	-582 M	-	-401 M	-413 M	-406 M	-402 M	-399 M	-278 M	-276 M	-270 M	-266 M	-280 M	-287 M	-287 M	-287 M	-287 M	-378 M	-378 M	-378 M	-378 M	-20.9 M	-20.9 M	-20.9 M	-20.9 M	-383 M	-383 M	-383 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	3.46 B	3.51 B	3.46 B	-	3.7 B	3.63 B	3.8 B	3.87 B	4.04 B	3.89 B	3.94 B	3.97 B	4.02 B	3.96 B	4.01 B	4.01 B	4.01 B	4.01 B	3.67 B	3.67 B	3.67 B	3.67 B	4.35 B	4.35 B	4.35 B	4.35 B	1.34 B	1.34 B	1.34 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	74 M	43.8 M	46.5 M	86.9 M	109 M	145 M	26 M	87.3 M	92 M	210 M	248 M	303 M	278 M	452 M	347 M	341 M	341 M	341 M	151 M	151 M	151 M	151 M	213 M	213 M	213 M	213 M	74.2 M	74.2 M	74.2 M	-	27.4 M	-	-	-	65.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	-	-	-	-	3.8 B	3.87 B	4.04 B	3.89 B	3.94 B	3.97 B	4.02 B	3.96 B	4.01 B	4.01 B	4.01 B	4.01 B	3.67 B	3.67 B	3.67 B	3.67 B	4.35 B	4.35 B	4.35 B	4.35 B	1.34 B	1.34 B	1.34 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-93.4 M	-57.5 M	-63.7 M	154 M	151 M	135 M	298 M	297 M	173 M	407 M	360 M	383 M	390 M	367 M	345 M	303 M	303 M	303 M	232 M	232 M	232 M	232 M	505 M	505 M	505 M	505 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency